Different animal models of prostatic inflammation and BHP reported a significant upregulation of NLRP3, caspase, and downstream cytokines, IL-1β and IL-18, suggesting that inflammasomes may perpetuate the inflammatory state associated with BPH [45,46,47]. Here, NLRP3 is linked to benign prostatic hyperplasia.